Answers are grounded in this paper and cite their sources.
The tricarboxylic (TCA) acid cycle is a process that occurs in the mitochondria which produces energy for cellular function. One multi-enzyme complex that regulates metabolic flux in the TCA cycle, therefore producing energy, is the malate dehydrogenase (MDH)-citrate synthase (CS) complex. Recently, overexpression of MDH has been found in a variety of cancers, and high concentrations of MDH have been used as a possible cancer prognosis. MDH has been found to increase the cytosolic concentration of NAD, therefore increasing glycolysis rates of proliferating cancer cells. Mitochondrial human malate dehydrogenase 2 (hMDH2) mutations have also been suggested to cause early-onset severe encephalopathy, which is a condition that is characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. The development of early-onset severe encephalopathy typically occurs before symptoms are present, and after symptoms arise, severe cognitive and motor delays become apparent. While there are several predicted structures of the MDH-CS complex, they are not consistent and lack enough information to be insightful due to variations in crosslinking and docking models. The lack of a known structure prevents us from understanding the channeling of oxaloacetate between the two enzymes and the regulation of this process. We aim to describe the structure of the hMDH2-hCS complex using small-angle X-ray scattering (SAXS) to identify a potential structural model leading to the characterization of the biochemical functions of this complex. We aim to empirically support a hypothetical model to provide more information about how the complex functions. hMDH2 and hCS were expressed in E. coli and purified separately before being cross-linked to form a stable complex. Structural analysis of hMDH2, hCS, and hMDH2-hCS was completed using size exclusion chromatography (SEC) coupled to SAXS and high-throughput (HT) SAXS. Modeling was performed using AlphaFold2 and HADDOCK. The SAXS data on hMDH2 and hCS alone is consistent with existing structural data and models. We are fitting and refining existing models based on biochemical studies to our SAXS data. The refined model based on the SAXS data will be useful for describing substrate channeling for this metabolon. These structural models will provide insights into potential therapeutic targets that are linked to human disease. This work was supported by the NSF MCB RUI-2322867. This work was also conducted at the Advanced Light Source (ALS), a national user facility operated by Lawrence Berkeley National Laboratory on behalf of the Department of Energy, the NIH project ALS-ENABLE (P30 GM124169), and a High-End Instrumentation Grant S10OD018483.
No takes yet. Share an insight, caveat, or question.
Kayll et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: